Furosemide/Digoxin
- Generic Name
- Furosemide/Digoxin
ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2019-03-20
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT03334240
- Locations
- 🇳🇱
LUMC/Centre For Human Drug Research, Leiden, Netherlands
A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
Phase 2
Completed
- Conditions
- Cutaneous Warts
- Interventions
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2016-07-28
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT02333643
- Locations
- 🇳🇱
LUMC/Centre for Human Drug Research, Leiden, Netherlands
First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2014-05-23
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT02106260
- Locations
- 🇳🇱
Centre for Human Drug Research, Zernikedreef 8, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath